Resumen

BANGALEE, V  y  SULEMAN, F. Is there transparency in the pricing of medicines in the South African private sector?. SAMJ, S. Afr. med. j. [online]. 2018, vol.108, n.2, pp.82-83. ISSN 2078-5135.  http://dx.doi.org/10.7196/samj.2018.v108i2.12815.

Recent investigations by the Competition Commission of South Africa (SA) of suspected excessive pricing of cancer medicines in SA by three global pharmaceutical companies have once again drawn attention to increasing medicine pricing transparency and warrant further public debate.

        · texto en Inglés     · Inglés ( pdf )